3 Best MFS Mutual Funds You Must Definitely Buy

Founded in 1924, MFS (Massachusetts Financial Services) had $673.2 billion in assets under management as of July 31, 2021. The company deals in more than 80 portfolios, which invest in both domestic and global stocks along with fixed-income debt securities. It focuses on providing a wide variety of financial products and services to fulfill the needs of investors as well as 10,000 investment professionals.

MFS is headquartered in Boston, MA and has investment offices located in Hong Kong, Sao Paulo, Singapore, Toronto, London, Mexico City, Sydney and Tokyo. The company has a dedicated staff of more than 1,900, who efficiently address its clients' needs. Its investment approach includes integrated study, international cooperation and expertise in risk management.

Below we share with you three top-rated MFS mutual funds. Each sports a Zacks Mutual Fund Rank #1 (Strong Buy) or #2 (Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.

MFS Mid Cap Value Fund Class R4 MVCJX aims for capital appreciation and invests the majority of its assets in companies with medium-market capitalization. Such companies have market capitalization similar to those companies that are included on the Russell Midcap Value Index. MVCJX sports a Zacks Mutual Fund Rank #2 and has three-year annualized returns of 12.8%.

Kevin J. Schmitz is the fund manager of MVCJX since 2008.

MFS Municipal Income Fund Class A1 MMIDX invests the bulk of its assets in municipal securities that are believed to provide interest income free from federal income tax. MMIDX seeks returns through tax-free income and growth of capital. The fund may invest more than one-fourth of its assets in those municipal instruments that are related to education, healthcare, utilities and housing. MMIDX carries a Zacks Mutual Fund Rank #1 and has three-year annualized returns of 5.4%.

As of the end of June 2021, MMIDX held 199 issues with 6.52% of its assets invested in Microsoft Corp.

MFS Growth Fund Class R3 MFEHX focuses on capital appreciation by investing primarily in equity securities. The fund’s advisor invests MFEHX’s assets in stocks of companies that the advisor believes have the potential for more-than-average earnings growth against the other growth companies. MFEHX sports a Zacks Rank #1 and has three-year annualized returns of 23%.

MFEHX has an expense ratio of 0.87% compared with the category average of 0.99%.

To view the Zacks Rank and the past performance of all MFS mutual funds, investors can click here to see the complete list of funds.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.